1-5 of 5
Todd D. Armstrong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

Brian J. Christmas, Christine I. Rafie, Alexander C. Hopkins, Blake A. Scott, Hayley S. Ma, Kayla A. Cruz, Skylar Woolman, Todd D. Armstrong, Roisin M. Connolly, Nilo A. Azad, Elizabeth M. Jaffee, Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (12): 1561–1577.
https://doi.org/10.1158/2326-6066.CIR-18-0070
Published: 03 December 2018
View article titled, Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Open the PDF for Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs in another window
Includes: Supplementary data
Journal Articles

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Jeremy B. Foote, Marleen Kok, James M. Leatherman, Todd D. Armstrong, Bridget C. Marcinkowski, Laureen S. Ojalvo, David B. Kanne, Elizabeth M. Jaffee, Thomas W. Dubensky, Jr, Leisha A. Emens
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (6): 468–479.
https://doi.org/10.1158/2326-6066.CIR-16-0284
Published: 01 June 2017
View article titled, A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Open the PDF for A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice in another window
Includes: Supplementary data
Journal Articles

Special Conference on Tumor Immunology and Immunotherapy: A New Chapter

Katelyn T. Byrne, Robert H. Vonderheide, Elizabeth M. Jaffee, Todd D. Armstrong
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (6): 590–597.
https://doi.org/10.1158/2326-6066.CIR-15-0106
Published: 03 June 2015
View article titled, Special Conference on Tumor Immunology and Immunotherapy: A New Chapter
Open the PDF for Special Conference on Tumor Immunology and Immunotherapy: A New Chapter in another window
Journal Articles

Apoptosis-Regulated Low-Avidity Cancer-Specific CD8+ T Cells Can Be Rescued to Eliminate HER2/neu–Expressing Tumors by Costimulatory Agonists in Tolerized Mice

Chelsea M. Black, Todd D. Armstrong, Elizabeth M. Jaffee
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2014) 2 (4): 307–319.
https://doi.org/10.1158/2326-6066.CIR-13-0145
Published: 03 April 2014
View article titled, Apoptosis-Regulated Low-Avidity Cancer-Specific CD8<sup>+</sup> T Cells Can Be Rescued to Eliminate HER2/neu–Expressing Tumors by Costimulatory Agonists in Tolerized Mice
Open the PDF for Apoptosis-Regulated Low-Avidity Cancer-Specific CD8<sup>+</sup> T Cells Can Be Rescued to Eliminate HER2/neu–Expressing Tumors by Costimulatory Agonists in Tolerized Mice in another window
Includes: Supplementary data
Journal Articles

Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances

Bridget P. Keenan, Elizabeth M. Jaffee, Todd D. Armstrong
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (1): 16–23.
https://doi.org/10.1158/2326-6066.CIR-13-0011
Published: 10 July 2013
View article titled, Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances
Open the PDF for Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances in another window
Includes: Supplementary data